REINHART PARTNERS, LLC. - ENCOMPASS HEALTH CORP ownership

ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 351 filers reported holding ENCOMPASS HEALTH CORP in Q1 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
REINHART PARTNERS, LLC. ownership history of ENCOMPASS HEALTH CORP
ValueSharesWeighting
Q3 2023$50,151,893
-0.3%
746,752
+0.5%
2.60%
+2.2%
Q2 2023$50,307,174
+24.6%
742,980
-0.5%
2.55%
+16.6%
Q1 2023$40,390,419
+85702.0%
746,588
-5.1%
2.19%
-14.3%
Q4 2022$47,074
-99.9%
787,066
-5.4%
2.55%
+10.0%
Q3 2022$37,640,000
-27.1%
832,178
-9.7%
2.32%
-18.2%
Q2 2022$51,655,000
-23.8%
921,588
-3.4%
2.83%
-13.7%
Q1 2022$67,825,000
+13.2%
953,801
+3.9%
3.28%
+14.3%
Q4 2021$59,892,000
+12.3%
917,745
+51.9%
2.87%
+6.1%
Q3 2021$53,309,000
-7.1%
604,274
-17.8%
2.71%
-5.0%
Q2 2021$57,386,000
-3.0%
735,434
+1.8%
2.85%
-7.3%
Q1 2021$59,152,000
+0.7%
722,246
+1.6%
3.08%
-13.8%
Q4 2020$58,765,000
+24.5%
710,660
-2.1%
3.57%
+0.6%
Q3 2020$47,184,000
+7.1%
726,140
+2.1%
3.55%
+6.1%
Q2 2020$44,042,000
+0.1%
711,158
+3.5%
3.34%
-21.6%
Q1 2020$43,997,000
-3.2%
687,133
+4.7%
4.26%
+27.6%
Q4 2019$45,452,000
+31.6%
656,158
+20.2%
3.34%
+4.1%
Q3 2019$34,533,000
-1.5%
545,726
-1.3%
3.21%
+3.9%
Q2 2019$35,049,000
+39.9%
553,171
+28.9%
3.09%
+32.0%
Q1 2019$25,055,000
+47.9%
429,018
+56.3%
2.34%
+29.4%
Q4 2018$16,939,000
-22.1%
274,536
-1.6%
1.81%
-8.0%
Q3 2018$21,742,000
-15.3%
278,916
-26.4%
1.97%
-20.2%
Q2 2018$25,671,000
-6.1%
379,074
-20.7%
2.46%
-12.5%
Q1 2018$27,331,000478,0732.82%
Other shareholders
ENCOMPASS HEALTH CORP shareholders Q1 2018
NameSharesValueWeighting ↓
Iron Triangle Partners LP 400,000$25,612,0009.91%
REINHART PARTNERS, LLC. 687,133$43,997,0004.26%
RK Capital 147,290$9,431,0004.24%
HealthCor Management, L.P. 1,525,809$97,698,0004.18%
Integral Health Asset Management, LLC 115,000$7,363,0003.24%
Sivik Global Healthcare LLC 32,500$7,733,0003.05%
Copeland Capital Management, LLC 635,514$40,692,0002.48%
Rock Springs Capital Management LP 815,000$52,184,0002.16%
Endurant Capital Management LP 55,614$3,561,0001.61%
Advantage Alpha Capital Partners LP 70,005$4,482,0001.60%
View complete list of ENCOMPASS HEALTH CORP shareholders